Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Gen Digital
GEN
$18B
| $4.92M | 0.01% |
179,338
-66,100
| -27% | -$1.81M |
|
1452
Bassett Furniture
BSET
$142M
| $4.91M | 0.01% |
339,861
+5,100
| +2% | +$73.7K |
|
1453
Townsquare Media
TSQ
$115M
| $4.91M | 0.01% |
483,152
+800
| +0.2% | +$8.13K |
|
1454
Akebia Therapeutics
AKBA
$774M
| $4.91M | 0.01% |
3,717,800
-197,000
| -5% | -$260K |
|
1455
Information Services Group
III
$253M
| $4.91M | 0.01% |
1,486,609
-25,900
| -2% | -$85.5K |
|
1456
Brown-Forman Class A
BF.A
$13.1B
| $4.9M | 0.01% |
101,976
-16,400
| -14% | -$789K |
|
1457
Donegal Group Class A
DGICA
$711M
| $4.88M | 0.01% |
331,311
-9,600
| -3% | -$142K |
|
1458
Pebblebrook Hotel Trust
PEB
$1.39B
| $4.85M | 0.01% |
366,795
+117,000
| +47% | +$1.55M |
|
1459
Privia Health
PRVA
$2.79B
| $4.85M | 0.01% |
266,300
+201,800
| +313% | +$3.67M |
|
|
CMRC
1460
Commerce.com, Inc. Series 1 Common Stock
CMRC
$367M
| $4.82M | 0.01% |
824,652
-34,448
| -4% | -$202K |
|
1461
Photronics
PLAB
$1.33B
| $4.82M | 0.01% |
194,595
-1,800
| -0.9% | -$44.6K |
|
1462
Genpact
G
$7.43B
| $4.82M | 0.01% |
122,849
+116,049
| +1,707% | +$4.55M |
|
1463
Euroseas
ESEA
$448M
| $4.81M | 0.01% |
120,907
+1,107
| +0.9% | +$44K |
|
1464
Visa
V
$660B
| $4.8M | 0.01% |
+17,469
| New | +$4.8M |
|
1465
PetMed Express
PETS
$57.8M
| $4.8M | 0.01% |
1,303,269
+38,700
| +3% | +$142K |
|
1466
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$5.48B
| $4.78M | 0.01% |
143,800
-25,333
| -15% | -$842K |
|
1467
VanEck Merk Gold Trust
OUNZ
$1.97B
| $4.77M | 0.01% |
187,990
+85,190
| +83% | +$2.16M |
|
1468
James Hardie Industries plc
JHX
$11.6B
| $4.76M | 0.01% |
118,627
-3,000
| -2% | -$120K |
|
1469
Relay Therapeutics
RLAY
$695M
| $4.75M | 0.01% |
671,095
-237,942
| -26% | -$1.68M |
|
|
DDL
1470
Dingdong
DDL
$475M
| $4.74M | 0.01% |
1,335,793
+645,593
| +94% | +$2.29M |
|
1471
JetBlue
JBLU
$1.85B
| $4.74M | 0.01% |
+722,400
| New | +$4.74M |
|
1472
Ichor Holdings
ICHR
$578M
| $4.72M | 0.01% |
148,400
-16,000
| -10% | -$509K |
|
1473
Pearson
PSO
$9.16B
| $4.72M | 0.01% |
347,700
-73,920
| -18% | -$1M |
|
1474
Cullinan Oncology
CGEM
$385M
| $4.72M | 0.01% |
281,800
-139,908
| -33% | -$2.34M |
|
1475
Bankwell Financial Group
BWFG
$361M
| $4.72M | 0.01% |
157,503
+13,900
| +10% | +$416K |
|